Gregory Holt, MD
Orthopaedic Surgery · Tulsa, OKNPI 1548221278
Payments from drug & device makers
Across 30 payments — averaging $100.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Omnilife Science, Inc$2K
- Anika Therapeutics, Inc.$230
- Miach Orthopaedics, Inc.$161
- Arthrosurface Incorporated$101
- Embody, Inc.$97
- Smith+Nephew$56
- plus $126 from 4 others
What the payments were for
- Consulting fees$1,50050%
- Food & beverage$1,52750%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Omnilife Science, Inc | 16 | $2,256 |
| Anika Therapeutics, Inc. | 3 | $230 |
| Miach Orthopaedics, Inc. | 1 | $161 |
| Arthrosurface Incorporated | 1 | $101 |
| Embody, Inc. | 1 | $97 |
| Smith+Nephew | 2 | $56 |
| Pacira Therapeutics, Inc. | 2 | $37 |
| Catalyst Orthoscience | 1 | $35 |
| Kowa Pharmaceuticals America, Inc. | 1 | $28 |
| Amgen | 2 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNIBotics 3.0$184
- Corin Knees$118
- HemiCAP Shoulder$101
How this compares
$3,027 in reported general payments places this provider in the 40th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 155 | $2,271 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $1,449 |
| Meloxicam | 305 | $910 |
| Celecoxib | 16 | $386 |
| Cyclobenzaprine Hcl | 22 | $376 |
| Gabapentin | 12 | $117 |
| Diclofenac Sodium | 11 | $106 |
| Tramadol Hcl | 18 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tulsa
- Yogesh MittalTulsa$6.7M
- Brian ChalkinTulsa$1.9M
- Sarat KunapuliTulsa$170K
- Kasra AhmadiniaTulsa$138K
- Keivan AbtahiTulsa$77K
- Rodney PlasterTulsa$61K
- Garrett WallerTulsa$52K
- Landon StallingsTulsa$46K
- Travis SmallTulsa$39K
- Blake ShockleyTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.